Acta Veterinaria et Zootechnica Sinica ›› 2025, Vol. 56 ›› Issue (3): 1419-1430.doi: 10.11843/j.issn.0366-6964.2025.03.040

• Preventive Veterinary Medicine • Previous Articles     Next Articles

Prokaryotic Expression of Eimeria necatrix ROP30 Protein and Its Immunoprotective Efficacy in Chicken

LI Huizhong1,2(), ZHANG Chi1,2, YAN Danli1,2, SONG Penghui1,2, WANG Feiyan1,2, FENG Qianqian1,2, LIU Dandan1,2, XU Jinjun1,2, TAO Jianping1,2,*()   

  1. 1. College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China
    2. Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, China
  • Received:2024-05-15 Online:2025-03-23 Published:2025-04-02
  • Contact: TAO Jianping E-mail:1067253182@qq.com;yzjptao@126.com

Abstract:

This study aimed to clone and express EnROP30 gene of Eimeria necatrix, and to evaluate the immune protection of recombinant protein EnROP30 in chicken. EnROP30 gene was cloned from total RNA of the second generation merozoites (MZ-2) of E. necatrix by RT-PCR, and inserted into the pGEM-T-Easy vector by TA cloning. After sequencing analysis, EnROP30 cDNA was subcloned to the pET-28a(+) vector to obtain a recombinant prokaryotic plasmid. After transformed into E. coli BL21, the recombinant plasmid pET28a(+)-EnROP30 was induced to express by IPTG, and the recombinant protein rEnROP30 was identified and purified. BALB/c mice were immunized with the purified recombinant protein to prepare the anti-rEnROP30 polyclonal antibodies, which was used to detect the native protein EnROP30 and its localization in sporozoites (SZ) and MZ-2 of E. necatrix by Western blot and indirect immunofluorescence assay, respectively. Finally, the transcriptional level of EnROP30 in SZ and MZ-2 was analyzed by qRT-PCR. Three groups of chickens were immunized with rEnROP30 at three different doses (200 μg, 100 μg and 50 μg per chicken), respectively. At the same time, two groups of chickens, namely the unimmunized and challenged (UC) group, and the unimmunized and unchallenged (UU) group, were used as the controls. The immune protective effects were evaluated based on the survival rate, weight gain, relative weight gain, oocyst reduction, lesion score and anticoccidial index (ACI) of each group. The results showed that the target gene was 1 605 bp, coding 534 amino acids with a predicted molecular weight of 55.55 ku. The recombinant protein was about 65 ku and predominantly expressed as soluble form. Western blot analysis showed that the recombinant protein could be specifically recognized by mouse anti-His monoclonal antibodies and the convalescent serum of the chickens infected with E. necatrix. Native protein EnROP30 was detected in SZ and MZ-2 and had a molecular weight of 62 ku. EnROP30 protein was located in the top of SZ and MZ-2. The transcription level of EnROP30 in MZ-2 was significantly higher than that in SZ (P < 0.05). The survival rate of all the groups was 100%. The weight gain of the immunized groups was higher than that of the UC group, but their lesion scores were significantly lower than that of the UC group (P < 0.05). In the group immunized with 100 μg rEnROP30 per chicken, the relative weight gain (92.96%), the oocyst reduction (66.87%) and ACI (158.96) were the highest. It was showed that EnROP30 gene was cloned and expressed successfully; rEnROP30 had a good protective efficacy against E. necatrix.

Key words: Eimeria necatrix, EnROP30, cloning, expression, protective efficacy

CLC Number: